Elite Pharmaceuticals (ELTP) EV to EBITDA (2020 - 2026)
Elite Pharmaceuticals' EV to EBITDA came in at 9.98 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 49.4% from 19.71 a year earlier but up 40.1% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) EV to EBITDA (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Elite Pharmaceuticals reported EV to EBITDA of 7.79, down 58.8% year-over-year; for FY2026 (ended Mar 31, 2026), it was 7.12, down 67.6% from FY2025.
- Going back by fiscal year, EV to EBITDA was 22.01 in FY2025 (+74.5%), 12.61 in FY2024 (+181.7%), 4.48 in FY2023 (+28.9%) and 3.47 in FY2022 (-79.3%).
- The five-year range for quarterly EV to EBITDA is 2.03 (fiscal Q3 2023) to 42.50 (fiscal Q3 2025).
- Year-over-year, EV to EBITDA has declined for four consecutive quarters, with growth averaging 16.2% over the last eight quarters.
- The fastest year-over-year change in EV to EBITDA over five years came in fiscal Q3 2024 (growth of 736.2%), and the weakest in fiscal Q4 2022 (a decline of 79.3%).
- Business Quant data shows ELTP's EV to EBITDA at 7.12 (Q4 2026), 9.89 (Q3 2026) and 15.25 (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn |
| 10 | Elite Pharmaceuticals | 258.43 Mn | 140.10 Mn | 13.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.85 |
| Mar 31, 2026 | 7.06 |
| Dec 31, 2025 | 9.80 |
| Sep 30, 2025 | 15.08 |
| Jun 30, 2025 | 19.47 |
| Mar 31, 2025 | 21.60 |
| Dec 31, 2024 | 41.32 |
| Sep 30, 2024 | 25.28 |
| Jun 30, 2024 | 14.12 |
| Mar 31, 2024 | 12.57 |
| Dec 31, 2023 | 17.01 |
| Sep 30, 2023 | 12.81 |
| Jun 30, 2023 | 5.58 |
| Mar 31, 2023 | 4.48 |
| Dec 31, 2022 | 2.03 |
| Sep 30, 2022 | 3.67 |
| Jun 30, 2022 | 8.00 |
| Mar 31, 2022 | 3.47 |
| Dec 31, 2021 | 5.26 |
| Sep 30, 2021 | 10.03 |
API Access
Elite Pharmaceuticals EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();